Oxenreiter, Monica M.
Lane, Anne Marie
Jain, Purva
Kim, Ivana K.
Gragoudas, Evangelos S.
Article History
Received: 7 January 2019
Revised: 27 February 2019
Accepted: 12 March 2019
First Online: 27 March 2019
Compliance with ethical standards
:
: Dr. Kim has received research support from Genentech and consulting and research fees from Genentech, Iconic Therapeutics, Allergan, Castle Biosciences, and Alcon. Dr. Gragoudas acts as an advisory/monitoring board member of Iconic Therapeutics, Aura Biosciences, and Astellas Pharma Inc. Dr. Gragoudas also holds a patent in Valeant Pharmaceuticals. Authors Oxenreiter, Lane, and Jain declare that they have no conflict of interest.
: This study was conducted in accordance with the ethical standards of the Mass Eye and Ear Institutional Review Board that granted an informed consent waiver for this retrospective chart review study.